TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Faron Pharmaceuticals Oy
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
1,153
|
520
|
906 |
Financial expenses |
361
|
311
|
146 |
Earnings before taxes |
-9,219
|
-6,146
|
-1,345 |
Total assets |
17,287
|
14,821
|
3,809 |
Current assets |
11,478
|
11,068
|
242 |
Current liabilities |
4,370
|
2,197
|
1,662 |
Equity capital |
10,883
|
11,178
|
-669 |
- share capital |
2,691
![]() |
2,691
![]() |
2,691 |
Employees (average) |
10
|
6
|
5 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
63.0%
|
75.4%
|
-17.6% |
Turnover per employee |
115
|
87
|
181 |
Profit as a percentage of turnover |
-799.6%
|
-1181.9%
|
-148.5% |
Return on assets (ROA) |
-51.2%
|
-39.4%
|
-31.5% |
Current ratio |
262.7%
|
503.8%
|
14.6% |
Return on equity (ROE) |
-84.7%
|
-55.0%
|
201.0% |
Change turnover |
633
|
-386 | |
Change turnover % |
122%
|
-43% | |
Chg. No. of employees |
4
|
1 | |
Chg. No. of employees % |
67%
|
20% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.